Carbidopa
DrugBank ID: DB00190
Summary
| Metric | Value |
|---|---|
| Total Predictions | 50 |
| KG+DL (Dual Validated) | 0 |
| DL Only | 50 |
| KG Only | 0 |
Predictions
| Indication | Score | Source |
|---|---|---|
| hereditary late onset Parkinson disease | 0.9927 | DL |
| X-linked parkinsonism-spasticity syndrome | 0.9883 | DL |
| juvenile onset Parkinson disease 19A | 0.9851 | DL |
| Rasmussen subacute encephalitis | 0.9843 | DL |
| PLA2G6-associated neurodegeneration | 0.9760 | DL |
| atypical juvenile parkinsonism | 0.9745 | DL |
| transaldolase deficiency | 0.9740 | DL |
| hemiparkinsonism-hemiatrophy syndrome | 0.9740 | DL |
| myelitis | 0.9740 | DL |
| fructose-1,6-bisphosphatase deficiency | 0.9709 | DL |
| parkinsonian-pyramidal syndrome | 0.9601 | DL |
| Lewy body dementia | 0.9599 | DL |
| paralysis agitans, juvenile, of Hunt | 0.9560 | DL |
| Parkinson disease | 0.9556 | DL |
| progressive supranuclear palsy-corticobasal syndrome | 0.9536 | DL |
| early-onset parkinsonism-intellectual disability syndrome | 0.9517 | DL |
| X-linked intellectual disability-ataxia-apraxia syndrome | 0.9487 | DL |
| X-linked intellectual disability-cerebellar hypoplasia syndrome | 0.9372 | DL |
| multiple system atrophy, parkinsonian type | 0.9346 | DL |
| CLCN4-related X-linked intellectual disability syndrome | 0.9318 | DL |
| lethal infantile mitochondrial myopathy | 0.9296 | DL |
| X-linked intellectual disability-spastic quadriparesis syndrome | 0.9282 | DL |
| hydrocephaly-cerebellar agenesis syndrome | 0.9228 | DL |
| NAA10-related syndrome | 0.9215 | DL |
| X-linked spasticity-intellectual disability-epilepsy syndrome | 0.9215 | DL |
| syndromic X-linked intellectual disability Chudley-Schwartz type | 0.9209 | DL |
| intellectual disability, X-linked, syndromic | 0.9208 | DL |
| MED12-related intellectual disability syndrome | 0.9205 | DL |
| X-linked intellectual disability-hypotonia-movement disorder syndrome | 0.9189 | DL |
| X-linked cerebral-cerebellar-coloboma syndrome syndrome | 0.9182 | DL |
| Paganini-Miozzo syndrome | 0.9181 | DL |
| X-linked intellectual disability, Stocco dos Santos type | 0.9174 | DL |
| X-linked intellectual disability with hypopituitarism | 0.9168 | DL |
| X-linked intellectual disability-precocious puberty-obesity syndrome | 0.9158 | DL |
| intellectual developmental disorder, X-linked, syndromic, Hackmann-Di Donato type | 0.9158 | DL |
| Prieto syndrome | 0.9157 | DL |
| Basilicata-Akhtar syndrome | 0.9118 | DL |
| X-linked intellectual disability-craniofacioskeletal syndrome | 0.9118 | DL |
| primary progressive freezing gait | 0.9102 | DL |
| holoprosencephaly 13, X-linked | 0.9101 | DL |
| lissencephaly type 1 due to doublecortin gene mutation | 0.9098 | DL |
| postencephalitic Parkinson disease | 0.8995 | DL |
| autosomal dominant striatal neurodegeneration type 1 | 0.8987 | DL |
| X-linked intellectual disability-acromegaly-hyperactivity syndrome | 0.8927 | DL |
| parkinsonian disorder | 0.8592 | DL |
| parkinson disease, autosomal dominant | 0.8216 | DL |
| parkinsonism with dementia of Guadeloupe | 0.8182 | DL |
| autosomal recessive Parkinson disease | 0.8083 | DL |
| Kufor-Rakeb syndrome | 0.7771 | DL |
| Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome | 0.7583 | DL |
External Links
Disclaimer
Predictions are for research purposes only and do not constitute medical advice.
Predictions are for research purposes only and do not constitute medical advice.